WallStSmart

AudioEye Inc (AEYE)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 542% more annual revenue ($258.90M vs $40.31M). AEYE leads profitability with a -7.6% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

AEYE

Avoid

25

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AEYEUndervalued (+67.1%)

Margin of Safety

+67.1%

Fair Value

$21.30

Current Price

$7.27

$14.03 discount

UndervaluedFair: $21.30Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AEYE0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

AEYE4 concerns · Avg: 3.8/10
PEG RatioValuation
2.374/10

Expensive relative to growth rate

Price/BookValuation
18.6x4/10

Trading at 18.6x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$89.47M3/10

Smaller company, higher risk/reward

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : AEYE

AEYE has a balanced fundamental profile.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : AEYE

The primary concerns for AEYE are PEG Ratio, Price/Book, EPS Growth.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

AEYE profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 25/100) and 43.0% revenue growth. AEYE offers better value entry with a 67.1% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

AudioEye Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

AudioEye, Inc. provides Internet, printing, streaming, and other media software solutions to individuals regardless of their network connection, device, location, or disabilities in the United States. The company is headquartered in Tucson, Arizona.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?